This site is intended for Healthcare professionals
HELP US PUT A SPOTLIGHT ON HEART FAILURE
Despite significant advances in heart failure (HF) treatment and prevention, morbidity and mortality remain high.1
Every heart failure patient, regardless of symptoms, remains at risk.
9 out of 10 patients
Even with current HF standard of care, the majority 9 out of ten patients remain symptomatic and are still at risk of hospitalisation for heart failure and cardiovascular death2*
|
9 out of 10 patientsEven with current HF standard of care, the majority |
Heart failure patients with reduced ejection fraction,
including those who may appear stable, have an unacceptably
high risk of hospitalisation and even death3
CV death or hospitalisation
based on NYHA II classification over a 4 year period
Data from the CHARM study, (2003)
Approximately 5 out of 10 patients
will die within 5 years after diagnosis4
Approximately 5 out of 10 patientswill die within 5 years after diagnosis4 |
|
In fact, HF is the leading cause of hospitalisation in patients over the age of 65.5
A BLIND SPOT
Despite the significant burden of HF, a new global survey shows that heart failure is a ‘blind spot’ for the public
and policymakers.
The survey, commissioned by AstraZeneca, in partnership with the World Heart Federation (WHF), showed low awareness
among policymakers of the societal and economic burden of the disease, and low awareness among the public on the
signs and symptoms of HF.6,7
190 policy makers from US, Canada, UK, Italy, Germany and Spain were surveyed in our recent study on HF awareness.
Of those,
Awareness of HF’s connections to hospital admissions is low among policymakers
Of those surveyed in our recent study on HF awareness,
Awareness of the 3 main symptoms is low amongst the general public surveyed
23%
Shortness of breath when
resting or being active
40%
feeling unusually
tired or weak
25%
Swelling of the feet, ankles, legs,
abdomen, or the small of the back
23%
Shortness of breath when
resting or being active
40%
feeling unusually
tired or weak
25%
Swelling of the feet, ankles, legs,
abdomen, or the small of the back
People were asked to select one disease for each symptom from a list of heart failure, diabetes, heart attack, stroke or asthma
People who connected symptoms with HF, compared to other conditions7,9
SPOTLIGHT ON HEART FAILURE
In order to bridge this gap, AstraZeneca and the World Heart Federation have partnered
on the Spotlight on Heart Failure campaign, designed to educate people about heart failure and
improve the prognosis for those who have been diagnosed.
Together we aim to:
1
Reduce the number of new
heart failure cases
2
Reduce the number of deaths
caused by heart failure
3
Reduce the frequency of hospitalisation for people living with heart failure
4
Improve the lives of people
suffering from heart failure and the
ones who care for them
1 Reduce the number |
2 Reduce the number |
3 Reduce the frequency |
4 Improve the lives of |
But the launch of this campaign is just the beginning.
We want to create a global movement to shine a light on
heart failure and improve the lives of everyone affected by it.
We want
your
expert
opinion
to help
shape this
campaign.
So we are asking -
what issues matter most to you?
Working together to shine a spotlight on heart failure
and promote heart health around the world.
Working together to shine a spotlight on heart failure and promote heart health around the world.